1
Clinical Trials associated with Allogeneic Pancreatic Islet Cells(National Institute of Allergy & Infectious Diseases)Islet Transplantation in Type I Diabetes With LEA29Y (Belatacept) Maintenance Therapy (CIT-04)
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation using a steroid-free, calcineurin-inhibitor-free belatacept based immunosuppressive medication, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
100 Clinical Results associated with Allogeneic Pancreatic Islet Cells(National Institute of Allergy & Infectious Diseases)
100 Translational Medicine associated with Allogeneic Pancreatic Islet Cells(National Institute of Allergy & Infectious Diseases)
100 Patents (Medical) associated with Allogeneic Pancreatic Islet Cells(National Institute of Allergy & Infectious Diseases)
100 Deals associated with Allogeneic Pancreatic Islet Cells(National Institute of Allergy & Infectious Diseases)